BioKinetic Europe Ltd

BioKineticEurope prides itself in enriching drug development through insightful trial design. We develop and design early phase trials with real world outcomes in mind, that are designed to be cost-effective and offer more intelligent results. Biokinetic is an independent Phase I/II clinical trial provider based in Northern Ireland, staffed with talented, dedicated professionals who have the kind of approach and experience that ensures the consistent quality and accuracy of testing that our clients rely upon. A company with a strong work ethic whose directors are very actively involved in study conduct. A company that offers a cost-effective service, on time and within budget.

Specialists in First in Man and Vaccine studies, BioKinetic has successfully completed studies for many international companies, covering a wide range of therapeutic areas. We have a robust and active database of over 10,000 volunteers. This, together with our agility and responsiveness to our clients, enables us to build long-term, sustainable relationships. We have an intelligent, collaborative approach to study design and conduct, coordinated by our expert team.

BioKinetic has been awarded MHRA Phase I Supplementary Accreditation and successfully completed both GCP and GMP Inspections. All studies are conducted to the most rigorous standards in accordance with the ICH GCP guidelines and the European Clinical Trials Directive. The exceptionally favourable UK regulatory environment, with the Phase I CTA approval timeline being 14 days, provides our clients with an added incentive to work with BioKinetic. Our quality assurance and quality control systems are models of best practice, ensuring exceptional accuracy and efficiency at all times.

Facilities
BioKinetic is host to a modern, comfortable and well-equipped 40-bed clinic, with recreation and dining areas. The facility also contains separate secured pharmacy and archiving facilities that are both temperature and humidity controlled, and dedicated dosing, phlebotomy and processing areas. Our bespoke study management system ensures deliverables are always met on time.
Volunteers deal only with a small team of specialized staff, creating a rapport which helps ensure protocol compliance.

Services
BioKinetic can provide a fully integrated package covering Phase I clinical studies. To extend our range of specialist services, we can tap into the extensive resources of our partner organizations to enable you to receive a range of services tailored to your study.

  • Study Design
  • Protocol Development
  • Clinical Conduct
  • Medical Writing
  • Regulatory Affairs

 

Contact details

14 Great Victoria Street
Belfast
Northern Ireland
BT2 7BA
Phone number: +44 (0)28 9081 8381
Web address: www.biokineticeurope.com
Email address: moira@biokineticeurope.com

Company details

Date established: 1996
Number of local staff: 30
Expertise:
  • First Administration to Man
  • Proof of Concept/Proof of Mechanism
  • TQTc
  • Drug Delivery
  • Drug/Drug Interaction
  • PK/PD
  • Food effect
  • BE/BA
Additional services:

Specialists in the following Therapeutic Areas:

  • Pain Management and Arthritis
  • Women’s Health
  • Diabetes and Prediabetes
  • Dermatology and Transdermals
  • Vaccines


Strategic Alliance Partners with like-minded service providers in:

  • Bioanalyis
  • Data Management & Statistical Analysis

 

Latest content